Free Trial

Analysts Issue Forecasts for Teladoc Health FY2027 Earnings

Teladoc Health logo with Medical background
Remove Ads

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Investment analysts at Zacks Research issued their FY2027 earnings estimates for shares of Teladoc Health in a research report issued on Wednesday, March 12th. Zacks Research analyst R. Department anticipates that the health services provider will post earnings per share of ($0.71) for the year. The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%.

Several other equities research analysts also recently commented on TDOC. Royal Bank of Canada boosted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. The Goldman Sachs Group cut their target price on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research note on Monday, March 3rd. Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Finally, Bank of America boosted their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a research report on Wednesday, February 12th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $11.26.

Remove Ads

Read Our Latest Report on Teladoc Health

Teladoc Health Price Performance

Teladoc Health stock traded down $0.47 during mid-day trading on Friday, reaching $8.40. The company had a trading volume of 5,312,070 shares, compared to its average volume of 6,002,063. The company has a market cap of $1.46 billion, a P/E ratio of -1.46 and a beta of 1.27. The business has a fifty day simple moving average of $10.54 and a 200 day simple moving average of $9.73. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $15.68.

Institutional Trading of Teladoc Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Whipplewood Advisors LLC purchased a new stake in Teladoc Health during the fourth quarter worth about $29,000. Versant Capital Management Inc grew its position in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after buying an additional 2,441 shares in the last quarter. Lindbrook Capital LLC grew its position in shares of Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after buying an additional 1,612 shares in the last quarter. Sterling Capital Management LLC grew its position in shares of Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after buying an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Teladoc Health during the fourth quarter worth about $60,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Read More

Earnings History and Estimates for Teladoc Health (NYSE:TDOC)

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads